A Comparison of Allograft Survival Between Cyclosporine and Tacrolimus Based Immunosuppressive Therapy in Kidney Transplantation: BIRDEM General Hospital Experience

Authors

  • Palash Mitra Assistant Registrar, Nephrology and Dialysis, BIRDEM General Hospital, Dhaka
  • Md Anisur Rahman Junior Consultant, Nephrology and Dialysis, BIRDEM General Hospital, Dhaka
  • Muhammad Abdur Rahim Assistant Professor, Nephrology and Dialysis, BIRDEM General Hospital, Dhaka
  • Mehruba Alam Ananna Assistant Professor, Nephrology and Dialysis, BIRDEM General Hospital, Dhaka
  • Tasrina Shamnaz Samdani Medical Officer, Coronary Care Unit, BIRDEM General Hospital, Dhaka
  • Ahmed Sharif Sumon Senior Medical Officer, Nephrology and Dialysis, BIRDEM General Hospital, Dhaka
  • Moontasim Akhtar Senior Medical Officer, Nephrology and Dialysis, BIRDEM General Hospital, Dhaka
  • Md Hasanul Kabir Senior Medical Officer, Nephrology and Dialysis, BIRDEM General Hospital, Dhaka
  • Mirza Shariful Haque Senior Medical Officer, Nephrology and Dialysis, BIRDEM General Hospital, Dhaka
  • Md Hedayetul Islam Pappu Senior Medical Officer, Nephrology and Dialysis, BIRDEM General Hospital, Dhaka
  • Md Mostarshid Billah Registrar, Nephrology and Dialysis, BIRDEM General Hospital, Dhaka
  • Tufayel Ahmed Chowdhury Registrar, Nephrology and Dialysis, BIRDEM General Hospital, Dhaka
  • Wasim Md Mohosinul Haque Associate Professor, Nephrology and Dialysis, BIRDEM General Hospital, Dhaka
  • Sarwar Iqbal Associate Professor, Nephrology and Dialysis, BIRDEM General Hospital, Dhaka
  • Md Abul Mansur Professor, Nephrology and Dialysis; Director, Transplant Unit, BIRDEM General Hospital, Dhaka

DOI:

https://doi.org/10.3329/birdem.v5i2.28384

Keywords:

Cyclosporine, graft survival, kidney transplantation, tacrolimus

Abstract

Introduction and Aims: Calcineurin inhibitors (CNIs), cyclosporine and tacrolimus, are one of the three major components of basic immunosuppressive therapy of kidney transplantation. Our aims were to study and compare the early and long-term graft survival in kidney transplant recipients who were receiving either of these two CNIs.

Methods: A questionnaire was formed and data were collected from the hospital records. We divided the patients in group 1 (patients on cyclosporine) and group 2 (patients on tacrolimus). We retrospectively evaluated patients clinical and laboratory findings.

Results: Group 1 included 50 patients who were on cyclosporine and group 2 included 61 patients who were on tacrolimus. Patients receiving tacrolimus showed almost similar renal function as cyclosporine receiving patients; serum creatinine was 1.27 ± 0.56 versus 1.42 ± 0.91mg/dL (p = 0.258), but they required less time for serum creatinine to become normal (4.71 ± 2.3 versus 7.26 ± 5.6 days, p=0.001) and less duration of post-transplant hospital stay (11.38 ± 3.33 versus 13.65 ± 5.0 days, p = 0.005). New onset diabetes was more pronounced in group 2 (29.5% versus 12 %, p = 0.025). On the other hand, acute rejection was only noted in group 1 (2 versus 0, p = 0.014). One-year and three-year graft survival for cyclosporine was 92.0% and 83.3%, and for tacrolimus was 96.2% and 89.2% respectively.

Conclusions: Tacrolimus is relatively favourable to cyclosporine in preventing acute allograft rejection and better immediate post-transplant graft function recovery.

Birdem Med J 2015; 5(2): 78-81

Downloads

Download data is not yet available.
Abstract
782
PDF
658

Author Biography

Palash Mitra, Assistant Registrar, Nephrology and Dialysis, BIRDEM General Hospital, Dhaka



Downloads

Published

2016-06-25

How to Cite

Mitra, P., Rahman, M. A., Rahim, M. A., Ananna, M. A., Samdani, T. S., Sumon, A. S., Akhtar, M., Kabir, M. H., Haque, M. S., Pappu, M. H. I., Billah, M. M., Chowdhury, T. A., Haque, W. M. M., Iqbal, S., & Mansur, M. A. (2016). A Comparison of Allograft Survival Between Cyclosporine and Tacrolimus Based Immunosuppressive Therapy in Kidney Transplantation: BIRDEM General Hospital Experience. BIRDEM Medical Journal, 5(2), 78–81. https://doi.org/10.3329/birdem.v5i2.28384

Issue

Section

Original Articles